Breast cancer (early) - intrabeam radiotherapy system: evaluation report
Contents:
01 - Overview prepared by NICE
02 - Assessment Report prepared by Southampton Health Technology Assessment Centre, University og Southampton (SHTAC)
03 - Comments on the Assessment Report - Carl Zeiss .
04 - Comments on the Assessment Report - Department of Health
05 - Comments on the Assessment Report - Royal College of Nursing
06 - Comments on the Assessment Report - Royal College Physicians
07 - Comments on the Assessment Report - Society and College of Radiographers
08 - Comments on the Assessment Report - Professor Jayant S Vaidya, author of the report on the TARGIT- A clinical trial
09 - Clinical expert comments on the Assessment Report - Coles
10 - Patient expert comments on the Assessment Report - Clarke
11 - Response to comments on the Assessment Report prepared by SHTAC
12 - Executive summary of technology manufacturer's submission - Carl Zeiss, IntraBeam
13 - Consultee submission - Breakthrough Breast Cancer
14 - Consultee submission - Breast Cancer Care
15 - Consultee submission - Institute of Physicians and Engineering in Medicine
16 - Consultee submission -NCRI-RCP-ACP
17 - Consultee submission -Royal College of Nursing
18 - Experts perspectives - Coles
19 - Patient experts perspectives - Eaton
20 - Patient experts perspectives - Clarke
21 - Patient experts prespectives - Harries
22 - Patient experts perspectives – Douek
Breast cancer (early) - intrabeam radiotherapy system: evaluation report
25 July 2014 (6.86 Mb 4 sec) |
This page was last updated: 25 July 2014